What is happening here is Pfizer has not sent any data, and therefore made approval to Medsafe—that is, there is no Medsafe recommendation. Pfizer tells us, however, that they'll have the data in a month or two; in fact, in a meeting we had with the ministry on Friday, they suggested maybe even by the end of the month.